Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05445843
Title Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression >= 1% and an STK11 Co-mutation.
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | NLD | ITA | HUN | GRC | GBR | FRA | ESP | DEU | BRA | BEL | AUT | ARG

Facility Status City State Zip Country Details
The Brown University Oncology Group Providence Rhode Island 02903 United States Details
Novartis Investigative Site Pilar Buenos Aires B1629AHJ Argentina Details
Novartis Investigative Site Buenos Aires C1426AGE Argentina Details
Novartis Investigative Site Cordoba X5000JHQ Argentina Details
Novartis Investigative Site Cordoba X5016KEH Argentina Details
Novartis Investigative Site Feldkirch A 6807 Austria Details
Novartis Investigative Site Wels A-4600 Austria Details
Novartis Investigative Site Sint Niklaas Oost Vlaanderen 9100 Belgium Details
Novartis Investigative Site Roeselare 8800 Belgium Details
Novartis Investigative Site Salvador BA 41825-010 Brazil Details
Novartis Investigative Site Belo Horizonte 30360 680 Brazil Details
Novartis Investigative Site Wuhan Hubei 430022 China Details
Novartis Investigative Site Wuhan Hubei 430030 China Details
Novartis Investigative Site Changsha Hunan 410013 China Details
Novartis Investigative Site Xian Shanxi 710061 China Details
Novartis Investigative Site Beijing 100021 China Details
Novartis Investigative Site Beijing 100036 China Details
Novartis Investigative Site Shanyang 110005 China Details
Novartis Investigative Site Zhengzhou 450008 China Details
Novartis Investigative Site Marseille cedex 20 Bouches Du Rhone 13915 France Details
Novartis Investigative Site Bron 69677 France Details
Novartis Investigative Site Montpellier 34070 France Details
Novartis Investigative Site Saint Herblain 44805 France Details
Novartis Investigative Site Strasbourg Cedex 67091 France Details
Novartis Investigative Site Halle (Saale) 06120 Germany Details
Novartis Investigative Site Harburg 31787 Germany Details
Novartis Investigative Site Kempten 87439 Germany Details
Novartis Investigative Site Oldenburg 26121 Germany Details
Novartis Investigative Site Tuebingen 72076 Germany Details
Novartis Investigative Site Athens 11526 Greece Details
Novartis Investigative Site Matrahaza 3200 Hungary Details
Novartis Investigative Site Thellakom Kottayam Kerala 686016 India Details
Novartis Investigative Site Varanasi Uttarpradesh 221005 India Details
Novartis Investigative Site Bari BA 70124 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Roma RM 00128 Italy Details
Novartis Investigative Site Orbassano TO 10043 Italy Details
Novartis Investigative Site Kuching Sarawak 93586 Malaysia Details
Novartis Investigative Site Pulau Pinang 10990 Malaysia Details
Novartis Investigative Site Breda 4818 CK Netherlands Details
Novartis Investigative Site Leeuwarden 8934 AD Netherlands Details
Novartis Investigative Site Porto 4100-180 Portugal Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Bangkok 10700 Thailand Details
Novartis Investigative Site Ankara 06500 Turkey Details
Novartis Investigative Site Ankara 06560 Turkey Details
Novartis Investigative Site Diyarbakir 21000 Turkey Details
Novartis Investigative Site Istanbul 34214 Turkey Details
Novartis Investigative Site Torquay Devon TQ2 7AA United Kingdom Details
Novartis Investigative Site Torquay TQ2 7AA United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field